Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia patients: a population-based study in Sweden - Wikidata - wikimedia - TriplyDB

Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia patients: a population-based study in Sweden

Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia patients: a population-based study in Sweden

http://www.wikidata.org/entity/Q28290841

about

Common genetic variants in candidate genes and risk of familial lymphoid malignancies Waldenström's macroglobulinemia: a clinical perspective in the era of novel therapeutics Role of immune escape mechanisms in Hodgkin's lymphoma development and progression: a whole new world with therapeutic implications Differential characteristics of Waldenström macroglobulinemia according to patterns of familial aggregation Evolution of Management and Outcomes in Waldenström Macroglobulinemia: A Population-Based Analysis.Immune-related and inflammatory conditions and risk of lymphoplasmacytic lymphoma or Waldenstrom macroglobulinemia.Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study Familial chronic lymphocytic leukemia Familial predisposition and genetic risk factors for lymphoma.Medical history, lifestyle, family history, and occupational risk factors for lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.Fludarabine in Waldenstrom's macroglobulinemia.Familial Aspects of Chronic Lymphocytic Leukemia, Monoclonal B-Cell Lymphocytosis (MBL), and Related Lymphomas.New developments in the management of Waldenström macroglobulinemia Anticipation in families with chronic lymphocytic leukemia and other lymphoproliferative disorders.Host genetics in follicular lymphoma Rare Circulating Cells in Familial Waldenström Macroglobulinemia Displaying the MYD88 L265P Mutation Are Enriched by Epstein-Barr Virus Immortalization.Waldenström macroglobulinemia with extramedullary involvement at initial diagnosis portends a poorer prognosis Familial aggregation of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia with solid tumors and myeloid malignancies.Familial monoclonal gammopathy of undetermined significance and multiple myeloma: epidemiology, risk factors, and biological characteristics.Precursors to lymphoproliferative malignancies.Relapsed Hodgkin lymphoma: management strategies Candidate genes of Waldenström's macroglobulinemia: current evidence and research.Elevated risk of chronic lymphocytic leukemia and other indolent non-Hodgkin's lymphomas among relatives of patients with chronic lymphocytic leukemia.Highly increased familial risks for specific lymphoma subtypes Risk of plasma cell and lymphoproliferative disorders among 14621 first-degree relatives of 4458 patients with monoclonal gammopathy of undetermined significance in Sweden.Novel aspects pertaining to the relationship of Waldenström's macroglobulinemia, IgM monoclonal gammopathy of undetermined significance, polyclonal gammopathy, and hypoglobulinemia.Patterns of hematologic malignancies and solid tumors among 37,838 first-degree relatives of 13,896 patients with multiple myeloma in Sweden.Genetic and immune-related factors in the pathogenesis of lymphoproliferative and plasma cell malignancies.Genetics- and immune-related factors in the pathogenesis of lymphoplasmacytic lymphoma/ Waldenström's macroglobulinemia.Patterns of survival and causes of death following a diagnosis of monoclonal gammopathy of undetermined significance: a population-based study.Targetable molecular pathways in classical Hodgkin's lymphoma.Lenalidomide in lymphomas and chronic lymphocytic leukemia.Waldenström macroglobulinaemia: the key questions.XIII. Waldenström's macroglobulinaemia: an indolent B-cell lymphoma with distinct molecular and clinical features.Waldenström macroglobulinemia: clinical and immunological aspects, natural history, cell of origin, and emerging mouse models Waldenström macroglobulinemia: from biology to treatment.Patterns of survival in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia: a population-based study of 1,555 patients diagnosed in Sweden from 1980 to 2005.Waldenstrom Macroglobulinemia: Genomic Aberrations and Treatment.Current treatment options and investigational drugs for Waldenstrom's Macroglobulinemia.Current options to manage Waldenström's macroglobulinemia.

P2860

Q24630753-1791439D-902B-4EB1-8A90-67DA332F162F Q26776391-F598F83A-6AF1-4BBA-BA00-CA143D2404E7 Q27011510-7694A110-73A2-4FEE-9EC1-A1D5ADCC1AC7 Q28277343-39855CD4-4ADA-4D26-9727-F17A0CCFFE26 Q33434251-CE6B18B0-0BC6-460C-A76C-A53B09AFB606 Q33803072-58E98547-AB1F-4858-BEBE-13F6BCABAB98 Q33931754-0C867D91-BA15-469B-AE52-BC54FFC841D1 Q33938058-8A4A5FDF-F395-4E83-852B-FF7842D76422 Q34044984-7E4CA731-ED0F-409A-8481-51D3C764E1D1 Q34137888-1CA7FBB2-2A2E-4714-9700-DE85274C0794 Q34351916-12523E54-02FE-40BD-86D7-FC8572F37B1C Q34441264-7B66EA22-0CAF-45DB-A45C-4CF5D6917A07 Q34553880-B1344390-DE6E-4CD0-A8DB-4E2900FB6880 Q34772134-2C903B8F-877A-490C-BB99-75FC17C982CD Q35038312-8F0DE9AE-C8DC-4920-A17C-78112C5ECC5F Q35767684-02401361-BC6B-46DC-A9CD-E70C872E753F Q35806665-0E037ED0-CF2F-4B1B-AE21-5F14026DA6EF Q35888716-BD9CEE30-6B51-4185-9441-81A3283348FB Q36015178-74120B3C-1D68-4A1C-A95F-C07F7EF02A3B Q36739877-12E2997D-E08A-409A-9504-A26948BED379 Q37008427-6B9C1E82-D1B0-42B0-8E67-76689F4EB4F3 Q37074275-99EAFC5D-020B-4CE4-89BA-F1C29C0AE3BE Q37175576-0D0AC892-401C-490B-A712-B95B731E886D Q37242775-4B46D148-4188-400E-BC23-E1E911C33CAE Q37275880-64D5E065-ACF7-4A6C-A19E-A482DEC8B2A1 Q37293654-621CF395-9791-4FA8-8CFE-9BC20A2B439F Q37332552-7DEA4FC2-7DCB-455E-9D11-FC6950EB6CC6 Q37406801-BDFEB32C-1615-4ACD-9182-27BA5B0CDBBA Q37442322-1BDC8266-355D-4EF9-97B7-FD9EA8CAACE3 Q37470926-1CA17570-498F-4E44-88EA-B3E9EA42209C Q37825891-27BECFE2-7A61-4968-8C3D-6D1BF8F13C1B Q38077277-5232C65B-8C92-45C1-9B18-13FBD62CE75E Q38104808-EB5D418A-F3C9-4ECC-BEF3-C5C4511C3FDC Q38115233-00868365-1917-450E-BD71-4B65F0F0436B Q38150849-39ECB68A-1C0F-4DCF-A016-8EAF7D697C06 Q38176969-910C6A9E-502B-4D46-9825-CB4D371BEE2D Q38429056-B149F70E-9789-401E-A020-1F508D0D3645 Q38970612-852473C5-4300-4374-9223-9F4C5B11B162 Q39044362-57ADEC50-BF0E-43CD-94D6-6D1998FE57D9 Q39358109-DF0466AB-020A-4860-8FA2-B6995D044F40

P2860

Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia patients: a population-based study in Sweden

http://www.wikidata.org/entity/Q28290841

description

2008 nî lūn-bûn

@nan

2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Risk of lymphoproliferative di ...... pulation-based study in Sweden

@ast

Risk of lymphoproliferative di ...... pulation-based study in Sweden

@en

Risk of lymphoproliferative di ...... pulation-based study in Sweden

@nl

type

label

Risk of lymphoproliferative di ...... pulation-based study in Sweden

@ast

Risk of lymphoproliferative di ...... pulation-based study in Sweden

@en

Risk of lymphoproliferative di ...... pulation-based study in Sweden

@nl

prefLabel

Risk of lymphoproliferative di ...... pulation-based study in Sweden

@ast

Risk of lymphoproliferative di ...... pulation-based study in Sweden

@en

Risk of lymphoproliferative di ...... pulation-based study in Sweden

@nl

P1433

Q28290841-545F3A52-4DE9-4DA2-BF1D-E9006539E761

P1476

Q28290841-DDCA9A12-A776-4B10-BD70-5E8C2B19FB1A

P2093

Q28290841-3076B70B-4EBB-4569-9E00-E1763EBB4D7B

Q28290841-5120E598-2138-46E5-BAC0-61657016907E

Q28290841-547BBE13-0563-4FFE-95ED-778AEE1DE745

Q28290841-A62969E3-4141-497E-9D30-EFA4B910A06A

Q28290841-E8F5CBDC-DAAE-4700-9CFB-8EBA325866F6

P2860

Q28290841-025818D0-EAD9-403D-997B-475533E83809

Q28290841-2088BC4F-F975-49DF-9DBF-F547E295E341

Q28290841-387A6DF7-FFF6-48DB-BB70-E37641ECB1A6

Q28290841-46071982-7B20-43B8-87F2-AA04ACB73CC8

Q28290841-4D7582D4-6AAE-424B-969D-A37470FC0F46

Q28290841-5BAC7D1F-B42A-46DF-AF97-8869D6D6B26D

Q28290841-60E543F4-E7AD-4D22-BFE0-B498FCF0AB65

Q28290841-624FBB4E-D76C-4455-865C-623933DD0B34

Q28290841-744034A5-AC94-4E5D-B379-865D3D96E1A6

Q28290841-76442D9B-056C-425A-AECD-9CCDCAA7AF43

P304

Q28290841-F3117C59-D89C-414F-9D2A-E087DB611935

P31

Q28290841-D7484EF7-AA13-42CC-ACFA-2BA7AB6D4E7B

P356

Q28290841-CE61620B-755D-47CE-AF29-ED860FE95811

P407

Q28290841-6ED9BFBE-73F6-4E9A-A20B-4500D2AF6A51

P433

Q28290841-B6B87FD8-9C47-4082-872D-B6E0E927B44E

P478

Q28290841-B3917C2F-765E-42E5-B34B-FD8B24F74041

P50

Q28290841-2D422FC3-5CA1-4FA7-AF09-81315E072D22

P577

Q28290841-7353A23F-3B81-4784-A12D-C5784616974A

P5875

Q28290841-76F2536F-BB2D-43A7-B3CC-7306302CB487

P698

Q28290841-2171842B-9D97-4D2C-8A05-1B87D57A0C0A

P921

Q28290841-134297E4-9A00-4A23-9B8E-7CFBB7F0BAD9

Q28290841-3F706978-917D-46CC-AE9E-C830706F7D76

P932

Q28290841-A1B5E3BB-DF29-4E49-AFA3-EC06B1E6236B

P356

BLOOD-2008-06-162768

P1433

P1476

Risk of lymphoproliferative di ...... pulation-based study in Sweden

@en

P2093

Ingemar Turesson

http://www.w3.org/2001/XMLSchema#string

Lynn R Goldin

http://www.w3.org/2001/XMLSchema#string

Magnus Björkholm

http://www.w3.org/2001/XMLSchema#string

Mary L McMaster

http://www.w3.org/2001/XMLSchema#string

Sigurdur Y Kristinsson

http://www.w3.org/2001/XMLSchema#string

P2860

Gene-expression profiling of Waldenstrom macroglobulinemia reveals a phenotype more similar to chronic lymphocytic leukemia than multiple myeloma

Chronic immune stimulation and subsequent Waldenström macroglobulinemia

Methods for testing familial aggregation of diseases in population-based samples: application to Hodgkin lymphoma in Swedish registry data.

Genetic susceptibility to lymphoma

Waldenström's macroglobulinemia: clinical features, complications, and management.

Waldenström macroglobulinemia neoplastic cells lack immunoglobulin heavy chain locus translocations but have frequent 6q deletions.

Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.

Ascertainment and diagnostic accuracy for hematopoietic lymphoproliferative malignancies in Sweden 1964-2003.

Familial occurrence of monoclonal gammapathies.

A case-control and family study of Waldenstrom's macroglobulinemia.

P304

3052-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2008-06-162768

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

112

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-10-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23171117

http://www.w3.org/2001/XMLSchema#string

P698

18703425

http://www.w3.org/2001/XMLSchema#string

P921

P932

2569164

http://www.w3.org/2001/XMLSchema#string